1-2 of 2
Lars Fransecky
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications

Clinical Trials & Observations
Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Gerald Wulf, Helmut Salih, Michael Lübbert, Michael W. M. Kühn, Thomas Schroeder, Hans Salwender, Katharina Götze, Jörg Westermann, Lars Fransecky, Karin Mayer, Bernd Hertenstein, Mark Ringhoffer, Hans-Joachim Tischler, Sigrid Machherndl-Spandl, Anika Schrade, Peter Paschka, Verena I. Gaidzik, Frauke Theis, Felicitas Thol, Michael Heuser, Richard F. Schlenk, Lars Bullinger, Maral Saadati, Axel Benner, Richard Larson, Richard Stone, Konstanze Döhner, Arnold Ganser
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5345–5355.
https://doi.org/10.1182/bloodadvances.2022007223
Published: 2022
Includes: Supplemental data
Journal Articles

Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy

Kai Rejeski, Andreas Burchert, Gloria Iacoboni, Pierre Sesques, Lars Fransecky, Veit Bücklein, Corinna Trenker, Rafael Hernani, Ralph Naumann, Jonas Schäfer, Viktoria Blumenberg, Christian Schmidt, Kristina Sohlbach, Michael von Bergwelt-Baildon, Emmanuel Bachy, Pere Barba, Marion Subklewe
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4719–4725.
https://doi.org/10.1182/bloodadvances.2022007776
Published: 2022
Includes: Supplemental data